Orbivan CF Interactions
There are 645 drugs known to interact with Orbivan CF (acetaminophen/butalbital), along with 14 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 43 are major, 556 are moderate, and 46 are minor.
- View all 645 medications that may interact with Orbivan CF
- View Orbivan CF alcohol/food interactions (1)
- View Orbivan CF disease interactions (14)
Most frequently checked interactions
View interaction reports for Orbivan CF (acetaminophen / butalbital) and the medicines listed below.
- aspirin
- atorvastatin
- baclofen
- butalbital
- cetirizine
- EpiPen (epinephrine)
- fenofibrate
- fluoxetine
- gabapentin
- hydrochlorothiazide
- hydroxyzine
- Klor-Con (potassium chloride)
- lisinopril
- Lomotil (atropine / diphenoxylate)
- meloxicam
- metformin
- Metoprolol Succinate ER (metoprolol)
- omeprazole
- oxybutynin
- pentoxifylline
- rizatriptan
- Sinemet CR (carbidopa / levodopa)
- testosterone
- Vicodin (acetaminophen / hydrocodone)
- Wellbutrin (bupropion)
Orbivan CF alcohol/food interactions
There is 1 alcohol/food interaction with Orbivan CF (acetaminophen / butalbital).
Orbivan CF disease interactions
There are 14 disease interactions with Orbivan CF (acetaminophen / butalbital) which include:
- alcoholism
- liver disease
- acute alcohol intoxication
- drug dependence
- liver disease
- porphyria
- rash
- respiratory depression
- PKU
- adrenal insufficiency
- depression
- hematologic toxicity
- osteomalacia
- paradoxical reactions
Report options
QR code containing a link to this page
More about Orbivan CF (acetaminophen / butalbital)
- Orbivan CF consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: analgesic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.